FDA.reportPublic FDA data

SPF 30

Manufacturer
KAVI Skin Solutions, Inc.
Effective date
2021-05-05
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:40:11

Label at a glance#

ProductSPF 30
Active ingredientOCTINOXATE, ZINC OXIDE
Label structure4 sections

Label contents#

Full prescribing information#

DESCRIPTION

DESCRIPTION SECTION

Moisturizing and clarifying skin while shielding it from the sun, KAVI SPF 30 is a 3-in-1 solution to skin rejuvenation and preservation. Completely oil and PABA free, KAVI SPF 30 is non-comedogenic (does not clog pores) and still waterproof.
Suitable for daily use, and an excellent form of broad-spectrum UVA/UVB protection when treating the skin with KAVI exfoliation masks.
Apply a layer of lotion to clean, dry skin twice per day or as necessary.

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

octyl-p-methoxycinnamate (7.5%),
benzophenone-3 (6%).

CAUTION

WARNINGS AND PRECAUTIONS SECTION

For external use only. If swallowed, seek medical attention. Avoid contact with eyes and mucous membranes. In case of eye contact, flush with cold water.

Back Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Product Front and Back PanelsProduct Front and Back PanelsMoisturizing and clarifying skin while shielding it from the sun, KAVI SPF 30 is a 3-in-1 solution to skin rejuvenation and preservation. Completely oil and PABA free, KAVI SPF 30 is non-comedogenic (does not clog pores) and still waterproof.
Suitable for daily use, and an excellent form of broad-spectrum UVA/UVB protection when treating the skin with KAVI exfoliation masks.
Apply a layer of lotion to clean, dry skin twice per day or as necessary.

Active Ingredients:
octyl-p-methoxycinnamate (7.5%),
benzophenone-3 (6%).

Inactive Ingredients:
propylene glycol, glyceryl monostearate, cetearyl alcohol, ceteareth-20, dimethicone, xanthan gum, capric-caprylic triglycerides, butylated hydroxytoluene, methylparaben, propylparaben, ethylenedinitrilotetraacetic acid disodium, magnesium ascorbyl phosphate, butylparaben, light fragrance, triethanolamine, deionized water.

CAUTION: For external use only. If swallowed, seek medical attention. Avoid contact with eyes and mucous membranes. In case of eye contact, flush with cold water.

KAVI Skin Solutions, Inc.
San Francisco, CA · www.kaviskin.com

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
42771-0010-12023-01-30C16284748780-1f386c649-bc1f-0266-e053-dadaa90a7c1aSPF 30

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
42771-0010-1SPF 301 g in 1 BOTTLE, PLASTICCREAM11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
42771-0010SPF 30 (OCTYL-P-METHOXYCINNAMATE) CREAM [KAVI SKIN SOLUTIONS, INC.]1Legacy NDC, 1 package rows20210506_c197bda8-3c44-3d40-e053-2995a90a76f6.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
42771-001042771-0010-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Name, UNII, Kind table
NameUNIIKind
OCTINOXATE4Y5P7MUD51ACTIB
ZINC OXIDESOI2LOH54ZACTIB
POLYOXYL 20 CETOSTEARYL ETHERYRC528SWUYIACT
CETOSTEARYL ALCOHOL2DMT128M1SIACT
XANTHAN GUMTTV12P4NEEIACT
TRICAPRINO1PB8EU98MIACT
PROPYLENE GLYCOL6DC9Q167V3IACT
GLYCERYL MONOSTEARATE230OU9XXE4IACT
DIMETHICONE92RU3N3Y1OIACT
BUTYLATED HYDROXYTOLUENE1P9D0Z171KIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
c197bda8-3c45-3d40-e053-2995a90a76f6c197bda8-3c44-3d40-e053-2995a90a76f62021-05-05WarningsExact identifier
spl id: c197bda8-3c45-3d40-e053-2995a90a76f6
spl set id: c197bda8-3c44-3d40-e053-2995a90a76f6

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.